NCT04041479View on ClinicalTrials.gov

Biomarker-guided rTMS for Treatment Resistant Depression

PHASE3RecruitingINTERVENTIONAL
Enrollment

348

Participants

Timeline

Start Date

September 17, 2021

Primary Completion Date

April 30, 2026

Study Completion Date

August 31, 2026

Conditions
Treatment Resistant DepressionMajor Depressive Disorder
Interventions
DEVICE

Repetitive Transcranial Magnetic Stimulation

iTBS rTMS targeting the DMPFC or left DLPFC

DEVICE

Repetitive Transcranial Magnetic Stimulation

iTBS rTMS targeting the left DLPFC

Trial Locations (2)

10065

RECRUITING

Weill Cornell Medicine, New York

94305

RECRUITING

Stanford University, Stanford

All Listed Sponsors
collaborator

National Institute of Mental Health (NIMH)

NIH

collaborator

Stanford University

OTHER

lead

Weill Medical College of Cornell University

OTHER